SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-02
👔
Contineum Therapeutics, Inc.
@CTNM_InsiderForm 4 Filing: Lorrain Daniel S. Sells $627,917.433 of $CTNM
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Contineum Therapeutics, Inc.
Ticker: $CTNM
Transaction Value
$627,917.433
Price/Share: $8.95
transaction date
2026-06-30
Shares: 70,188
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lorrain Daniel S., holds the title of Chief Scientific Officer at Contineum Therapeutics, Inc..
On 2026-06-30, the insider transacted 70,188 shares.The shares were transacted at a weighted average price of $8.95 per share, resulting in a total market-relevant value of $627,917.433.
Executive Summary Summary
Lorrain Daniel S. (Chief Scientific Officer) sold $628K of $CTNM
Post-Transaction Position: 139,372 shares
SEC Accession No: 0001628280-26-047058 (CIK: 1861550)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.